TGF-β inhibitor treatment also rescued the digit phenotype of mice with heterozygous Mir17-92 deletion, a genetic alteration close to that of patients with Feingold syndrome type 2, further supporting this notion (Supplementary Fig. 6a). Here, TGFB1 is linked to Feingold syndrome type 2.